Oneness Biotech Co., Ltd.

This study tests a new drug called FB825 in 100 adults with moderate-to-severe allergic asthma. The goal is to see if it can reduce asthma attacks and improve breathing compared to a placebo. Participants will receive either the drug or a placebo and be monitored for 24 weeks.

This study tests an experimental drug called FB825 for adults with moderate-to-severe atopic dermatitis (eczema). About 90 participants will receive either the drug or a placebo as a shot under the skin. The goal is to see if it reduces eczema severity and itching, and to check f…

This study tests a new medicine called FB704A for adults with severe asthma. The goal is to see if it is safe and can help control asthma symptoms. About 20 people will receive either the drug or a placebo over 8 weeks, with follow-up for 12 more weeks. Participants must have poo…

This early-stage study is testing a new drug, SNS851, in 52 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo by injection. The main goal is to check for side effects, not to treat any disease.